evaluation of OCTA following use of antiVEGF in retinal disease of eye in patients above 50 yrs
Not Applicable
- Conditions
- Health Condition 1: H353- Degeneration of macula and posterior pole
- Registration Number
- CTRI/2023/03/050175
- Lead Sponsor
- MAULANA AZAD MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PATIENTS OF EXUDATIVE AGE RELATED MACULAR DEGENERATION, WHO ARE ANTI VEGF NAIVE
SUBJECTS HAVING BEST CORRECTED VISUAL ACUITY OF AT LEAST 6/60
Exclusion Criteria
SUBJECTS HAVING OTHER SIGNIFICANT OCULAR AND SYSTEMIC DISEASES
RISK OF THROMBOEMBOLIC EVENTS AND/OR OCCURRENCE OF THESE WITHIN PAST 6 MONTHS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CHANGES IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY PARAMETERS <br/ ><br>1.FOVEAL AVASCULAR ZONE <br/ ><br>2.VESSEL DENSITY (SUPERFICIAL CAPILLARY PLEXUS , DEEP CAPILLARY PLEXUS AND FULL VESSEL DENSITY) <br/ ><br>3.CHOROIDAL NEOVASCULAR MEMBRANE FOLLOWING ANTI VEGFTimepoint: 1 MONTH
- Secondary Outcome Measures
Name Time Method CHANGES IN BEST CORRECTED VISUAL ACUITY FOLLOWING ANTI VEGF <br/ ><br>CHANGES IN POSTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY PARAMETERS (CENTRAL FOVEAL THICKNESS AND SUB FOVEAL CHOROIDAL THICKNESS) FOLLOWING ANTI VEGFTimepoint: 1 MONTH